AXIM Biotechnologies, Inc. (AXIM)
AXIM Stock Price Chart
Explore AXIM Biotechnologies, Inc. interactive price chart. Choose custom timeframes to analyze AXIM price movements and trends.
AXIM Company Profile
Discover essential business fundamentals and corporate details for AXIM Biotechnologies, Inc. (AXIM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
2 Sept 2014
Employees
6.00
Website
https://www.aximbiotech.comCEO
Catalina Valencia
Description
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing tumor cell growth and blocking metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
AXIM Financial Timeline
Browse a chronological timeline of AXIM Biotechnologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 17 Nov 2025
Earnings released on 2 Jun 2025
Earnings released on 2 Jun 2025
EPS came in at -$0.00 .
Earnings released on 17 Apr 2025
Earnings released on 19 Nov 2024
Earnings released on 19 Aug 2024
EPS came in at -$0.01 , while revenue for the quarter reached $17.48K .
Earnings released on 20 May 2024
EPS came in at -$0.00 , while revenue for the quarter reached $52.98K .
Earnings released on 22 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $12.86K .
Earnings released on 20 Nov 2023
EPS came in at $0.00 , while revenue for the quarter reached $9.58K .
Earnings released on 21 Aug 2023
EPS came in at -$0.02 , while revenue for the quarter reached $9.93K .
Earnings released on 22 May 2023
EPS came in at -$0.02 , while revenue for the quarter reached $7.40K .
Earnings released on 17 Apr 2023
EPS came in at $0.00 , while revenue for the quarter reached $7.56K .
Earnings released on 15 Nov 2022
EPS came in at -$0.02 , while revenue for the quarter reached $1.31K .
Earnings released on 16 Aug 2022
EPS came in at -$0.01 .
Earnings released on 23 May 2022
EPS came in at -$0.06 , while revenue for the quarter reached $4.81K .
Earnings released on 23 May 2022
EPS came in at -$0.02 .
Earnings released on 22 Nov 2021
EPS came in at -$0.02 , while revenue for the quarter reached $8.13K .
Earnings released on 23 Aug 2021
EPS came in at -$0.03 , while revenue for the quarter reached $14.88K .
Earnings released on 24 May 2021
EPS came in at -$0.01 , while revenue for the quarter reached $32.65K .
Earnings released on 15 Apr 2021
EPS came in at -$0.02 , while revenue for the quarter reached -$7.14K .
Earnings released on 20 Nov 2020
EPS came in at -$0.02 .
AXIM Stock Performance
Access detailed AXIM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.